BIOATLA INC. - COMMON
2.0950
08-November-24 11:26:36
15 minutes delayed
Stocks
-0.1250
-5.63%
Today's range
2.0650 - 2.2600
ISIN
N/A
Source
NASDAQ
-
BioAtla Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights Recent Progress
23 Mar 2023 15:05:00 By Nasdaq GlobeNewswire
-
16 Mar 2023 07:00:02 By Nasdaq GlobeNewswire
-
BioAtla Announces Change in Executive Leadership
27 Feb 2023 07:07:17 By Nasdaq GlobeNewswire
-
23 Feb 2023 07:00:01 By Nasdaq GlobeNewswire
-
BioAtla Provides Clinical Program Updates and Upcoming 2023 Milestones
10 Jan 2023 07:00:02 By Nasdaq GlobeNewswire
-
BioAtla to Participate in the 41st Annual J.P. Morgan Healthcare Conference
22 Dec 2022 07:00:01 By Nasdaq GlobeNewswire
-
BioAtla to Participate in the Jefferies London Healthcare Conference
08 Nov 2022 07:00:03 By Nasdaq GlobeNewswire
-
BioAtla Announces $65 Million Underwritten Offering of its Common Stock
04 Nov 2022 08:08:20 By Nasdaq GlobeNewswire
-
BioAtla Reports Third Quarter 2022 Financial Results and Highlights Recent Progress
03 Nov 2022 15:01:01 By Nasdaq GlobeNewswire
-
27 Oct 2022 07:00:02 By Nasdaq GlobeNewswire
-
BioAtla Reports Second Quarter 2022 Financial Results And Highlights Recent Progress
09 Aug 2022 15:05:01 By Nasdaq GlobeNewswire
-
BioAtla to Participate in the 2022 BTIG Biotechnology Conference
03 Aug 2022 07:00:01 By Nasdaq GlobeNewswire
-
02 Aug 2022 07:00:03 By Nasdaq GlobeNewswire
-
BioAtla to Participate in 2022 Jefferies Global Healthcare Conference
01 Jun 2022 15:05:00 By Nasdaq GlobeNewswire
-
BioAtla Reports First Quarter 2022 Financial Results and Highlights Recent Progress
04 May 2022 15:01:01 By Nasdaq GlobeNewswire
-
08 Apr 2022 07:00:00 By Nasdaq GlobeNewswire